Short answer
Yes. A day without a sore is not necessarily a day without virus on the skin, and most genital herpes is passed by people who have no symptoms at the time or do not know they carry it. In one HSV-2 cohort, virus turned up on 13.1% of lesion-free days in people with a symptom history and 8.8% in those without one. Those are study averages, not a schedule of safe days, which is exactly why disclosure and precautions matter even when you feel well.
Checked September 8, 2026 · Sources: CDC, JAMA, NEJM, listed at the end · This site is run by an employee of the company that owns PositiveSingles. Why that matters
What shedding actually is
Herpes alternates between two states. Most of the time it sits latent in nerve ganglia, doing nothing. Periodically it reactivates and travels back down the nerves to the skin, where it can be present and infectious. When that reactivation produces a sore, you see it. When it does not, or the sore is somewhere you never notice, that is asymptomatic shedding: virus on the skin, no symptoms, contagious anyway. Researchers measure it by testing repeated swabs, which is a different measurement from following couples to see who acquires HSV, the design behind the transmission guide.
What one HSV-2 study measured
Tronstein and colleagues followed 498 people with HSV-2. The chart compares lesion-free days in two groups: people who had recognized symptoms before enrollment, and people who had not.
HSV-2 was detected even on days without sores
Days without genital lesions · each tick = 0.1 percentage point · two groups in one cohort study
Tronstein et al. · JAMA · 2011
Read the data & limits
| Symptom history at enrollment | Positive / eligible days | Rate (95% CI) |
|---|---|---|
| History of symptoms | 2,708 / 20,735 | 13.1% (11.5 to 14.6%) |
| No recognized symptom history | 434 / 4,929 | 8.8% (6.3 to 11.5%) |
The study included 410 people with symptomatic HSV-2 and 88 with asymptomatic infection. Participants collected genital swabs for at least 30 days. This chart uses only days without reported genital lesions, not all sampled days.
These are aggregate study measurements. Individual shedding varied. A positive swab does not give the probability of transmission during a particular encounter. Symptom history is not a medication comparison, and this study does not establish an HSV-1 rate.
Both groups shed HSV-2 without lesions. The percentages describe sampled days across a group, not your next encounter, and they do not reveal a personal schedule of safe and unsafe days.
HSV-1 and medication need separate evidence
In a 2022 genital HSV-1 study, researchers detected shedding on 12.1% of sampled days at 2 months after the first episode and 7.1% at 11 months. Those were total genital shedding days, not only days without lesions, and they show why time since infection matters. In a separate valacyclovir trial, an HSV-2 shedding substudy detected virus on 2.9% of days in the medication group and 10.8% in the placebo group, which does not turn a shedding percentage into an equal percentage cut in transmission. Ask a clinician whether suppressive treatment fits your situation; the CDC notes the evidence differs between symptomatic HSV-2, asymptomatic HSV-2, and genital HSV-1.
Two things "no symptoms" means
People use "asymptomatic" for two different situations, and it helps to separate them. The first: you know you have HSV and are simply not having an outbreak right now. Shedding still happens on some days, daily antivirals compress those days, and avoiding contact during prodrome and outbreaks removes the highest-risk ones. The second: you have HSV but have never noticed symptoms, so you do not know. Some infections are mild or unrecognized, and a test result and symptom history need to be read together with a clinician; they do not pin down when the infection began. If a positive result was unexpected, ask what test was used, whether confirmation is needed, and what it can and cannot tell you, then make a plan for future partners.
What this means if you're positive
- Disclose even if you never have outbreaks. "I've never had symptoms" is true and reassuring, but it is not the same as "there's no risk", and a partner deserves the real shape of it.
- Discuss medication rather than assuming you need it. Suppressive therapy can reduce recurrences and, in studied populations, transmission, but its benefit depends on your type and history.
- Learn your prodrome. Many people get a recognizable warning, tingling, itching, or nerve achiness, a day or two before anything visible; treating prodrome as day one of an outbreak is one of the highest-value habits there is.
- Skin-to-skin is the mechanism. Condoms help but do not cover all shedding skin, which the condom guide explains.
Sources
- Tronstein E et al., JAMA, 2011. 498 people with HSV-2: virus on 2,708 of 20,735 lesion-free days (13.1%) with a symptom history, 434 of 4,929 (8.8%) without. DOI 10.1001/jama.2011.420.
- Genital HSV-1 shedding study, 2022. Shedding on 12.1% of days at 2 months, 7.1% at 11 months after first episode.
- Corey L et al., New England Journal of Medicine, 2004. Valacyclovir shedding substudy: 2.9% of days on treatment against 10.8% on placebo.
- CDC, STI Treatment Guidelines, genital herpes. Most transmission is from people who are asymptomatic or unaware. Consulted September 8, 2026.